Vascular malformations in the brain known as cerebral cavernous malformations (CCMs) are a cause of seizures and hemorrhagic stroke. Familial cases of CCM are caused by mutations in one of three genes – KRIT1, CCM2 or PDCD10 – and it has been hypothesised that the proteins they encode form a complex. However, Chan et al. now report that the molecular pathways perturbed by mutations in the different genes are distinct, despite causing similar clinical pathology. The authors used inducible, tissue-specific mouse models of CCM to show that loss of Pdcd10 has different effects on vascular development and endothelial signalling pathways than loss of Krit1 or Ccm2. Despite these differences, they found that loss of heterozygosity is the common genetic mechanism causing CCMs with both molecular phenotypes. These findings indicate that CCMs with similar pathology can be caused by multiple mechanisms, and that treatment strategies should take into account the causative mutation.
Two distinct routes to CCM pathology
Two distinct routes to CCM pathology. Dis Model Mech 1 May 2011; 4 (3): 278. doi:
Download citation file:
Advertisement
Cited by
History of our journals

As our publisher, The Company of Biologists, turns 100 years old, read about DMM’s history and explore the journey of each of our sister journals: Development, Journal of Cell Science, Journal of Experimental Biology and Biology Open.
A new perspective on disease research
DMM publishes perspectives – peer-reviewed articles that provide expert analysis of a topic important to the disease research community. Read our collection from authors presenting new or potentially controversial ideas or hypotheses, to help address future challenges and forge new directions.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
About us
Other journals from
The Company of Biologists